Results of clinical renal function tests in lithium patients
Abstract
Because there have been reports suggesting that patients who receive lithium are at risk for renal damage, the authors carried out extensive noninvasive testing of renal function in 43 patients who had been taking lithium for from 1 to 120 months. Their only abnormal finding was that the urine concentrating ability of these patients was moderately but asymptomatically impaired. They suggest that although patients receiving lithium should be carefully evaluated and tested, there is not enough evidence to justify not initiating or continuing lithium use in patients who might benefit from it.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
